The rising demand for improved healthcare delivery systems and an increase in the prevalence of chronic diseases are expected to create lucrative growth opportunities in the market.
The rising demand for improved healthcare delivery systems and an increase in the prevalence of chronic diseases are expected to create lucrative growth opportunities in the market. The global IV tubing sets and accessories market is expected to be worth US$ 1,206.4 million in 2024. The market is expected to increase at a 3.8% CAGR through 2034. By 2034, the market is expected to be worth more than US$ 1,750.5 million.
The growing aging population, rising prevalence of chronic diseases, and rising number of surgeries are predicted to boost market expansion. Furthermore, technological improvements, such as the introduction of smart IV tubing sets and accessories with features such as wireless communication and automatic data recording, are projected to drive market expansion.
The rising prevalence of malnutrition, particularly in developing and undeveloped nations, is likely to increase market demand for IV tubing sets and accessories. Malnutrition leads to several health problems, including a reduced immune system, a slower healing process, and an increased risk of infection.
The regulatory requirements for launching novel products into the IV tubing sets and accessories market are stringent, which can present an obstacle for the market. These standards are in place to ensure that all products used in medical settings are safe and effective, and they require significant testing and paperwork to prove adherence.
For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9521
Key Takeaways from the Market Study
The global IV tubing sets and accessories market is projected to expand at a CAGR of 3.8% from 2024 to 2034.
North America’s IV tubing sets and accessories industry is expected to rise at a sluggish CAGR of 3.3% from 2024 to 2034.
The market is expected to register a CAGR of 3.3% in the United States over the forecast period.
China's IV tubing sets and accessories market is expected to rise at a CAGR of 4.3% through 2034.
Based on the product type, the secondary IV tubing sets segment leads the market, with an expected share of 29.4% in 2024.
“The rising demand for disposable IV tubing sets and accessories due to concerns about infection and cross-contamination also propels the market forward." says a Fact.MR Analyst.
Leading Players Driving Innovation in the IV Tubing Sets and Accessories Market
C.R. Bard, Inc.; ICU Medical Inc.; Nipro Corporation; Poly Medicure Ltd.; Health Line International Corporation; Baxter International Inc.; Hospira Inc. (Pfizer Inc.); Becton, Dickinson Company (CareFusion); B. Braun Melsungen AG; Fresenius Kabi AG; Smiths Medical; Zyno Medical; Vygon; Perfect Medical Ind. Co. Ltd
Competition Landscape
The market is diverse with several players, ranging from small-scale firms to huge international enterprises. These companies are continuously attempting to develop novel products and expand their market reach through partnerships, collaborations, mergers, and acquisitions. Some of the prominent companies in the market are Baxter International Inc., Hospira Inc. (Pfizer Inc.), Becton, Dickinson Company (CareFusion), B. Braun Melsungen AG, and Fresenius Kabi AG
Recent Development in the Market
In 2022, Ivenix, Inc. announced that the company had entered into a legally binding contract with Fresenius Kabi to be purchased. By combining Ivenix's unique infusion system with Fresenius Kabi's intravenous fluids and infusion therapy options, American hospitals will have access to various infusion items.
Get Customization on this Report for Specific Research Solutions: https://www.factmr.com/connectus/sample?flag=S&rep_id=9521
IV Tubing Sets and Accessories Industry News:
Ivenix, Inc. disclosed in 2022 that it has signed a legally binding agreement for sale to Fresenius Kabi. Through the blending of Ivenix's novel infusion system and the intravenous liquids and infusion treatment options by Fresenius Kabi, the American hospitals will have access to a wide range of infusion commodities.
Check out More Related Studies Published by Fact.MR:
The disinfection caps market , valued at US$ 350 million in 2022, is projected to grow at a 3.7% CAGR, reaching US$ 420 million by 2027.
Pneumatic nebulizer market sales, worth US$ 699 million in 2022, are expected to increase at a 4% CAGR, reaching US$ 850.4 million by 2027.
The rare hemophilia factors market , valued at US$ 290 million in 2022, is set to expand at a 6% CAGR, reaching US$ 520 million by 2032, with fresh frozen plasma usage growing at 6.2%.
Skincare devices market , valued at US$ 12 billion in 2021, are forecasted to reach US$ 14 billion in 2022 and expand 3.1x to US$ 43.48 billion by 2032.
The nerve monitoring devices market , worth US$ 1.3 billion in 2021, is projected to grow 5.6% Y-o-Y, reaching US$ 1.4 billion in 2022.
The knee cartilage repair market , valued at US$ 3.92 billion in 2022, is expected to grow at a 5% CAGR, reaching US$ 5 billion by 2027.
The electrosurgery devices market , worth US$ 5.2 billion in 2021, is projected to grow at a 4% CAGR, reaching US$ 8 billion by 2032.
The syringes market , valued at US$ 17.89 billion in 2022, is expected to expand at a 4.2% CAGR, reaching US$ 26.99 billion by 2032.
